Join the Larotrectinib group to help and get support from people like you.
Larotrectinib News
FDA Medwatch Alert: Bayer Issues Voluntary Recall Nationwide of Vitrakvi (larotrectinib) Oral Solution 20 mg/mL Due to Presence of Microbial Contamination
November 17, 2023 – WHIPPANY, N.J., Bayer is voluntarily recalling one lot of Vitrakvi® (larotrectinib) Oral Solution 20 mg/mL in 100mL glass bottles to the consumer/user level. The product is being r...
FDA Approves Vitrakvi (larotrectinib) for TRK Fusion Cancers
November 26, 2018 – The U.S. Food and Drug Administration today granted accelerated approval to Vitrakvi (larotrectinib), a treatment for adult and pediatric patients whose cancers have a specific...
Ask a question
To post your own question to this support group, sign in or create an account.